Eilertsen, Rune Krogh https://orcid.org/0009-0008-1249-5190
Gerdts, Eva https://orcid.org/0000-0003-4109-2311
Waje-Andreassen, Ulrike https://orcid.org/0000-0003-3240-6040
Cramariuc, Dana https://orcid.org/0000-0002-1593-2017
Sindre, Rasmus Bach https://orcid.org/0009-0001-2342-8849
Pirinen, Jani https://orcid.org/0000-0002-4030-9358
Suihko, Satu https://orcid.org/0000-0002-6873-2502
Sarkanen, Tomi https://orcid.org/0000-0001-8815-2807
Virtanen, Marko https://orcid.org/0000-0001-9674-0772
Ryödi, Essi
Jäkälä, Pekka https://orcid.org/0000-0002-8410-6915
Hedman, Marja https://orcid.org/0000-0003-1318-8287
Redfors, Petra https://orcid.org/0000-0001-5956-4255
Bech-Hanssen, Odd https://orcid.org/0000-0002-9572-9819
Huhtakangas, Juha https://orcid.org/0000-0001-7143-519X
Ylikotila, Pauli https://orcid.org/0009-0002-4126-9666
Lautamäki, Riikka
Saraste, Antti
von Sarnowski, Bettina https://orcid.org/0000-0002-1458-476X
Busch, Raila https://orcid.org/0009-0006-4676-3363
Fonseca, Ana Catarina https://orcid.org/0000-0001-6913-5526
Almeida, Ana G. https://orcid.org/0000-0003-0360-4363
Martínez-Sánchez, Patricia https://orcid.org/0000-0003-1945-4435
Kõrv, Janika https://orcid.org/0000-0002-6074-0727
Muda, Piibe https://orcid.org/0009-0004-1363-4501
Ferdinand, Phillip https://orcid.org/0000-0002-8715-2917
Oxley, Cheryl
Zakarkaitė, Diana https://orcid.org/0000-0003-3299-7135
Ryliškienė, Kristina https://orcid.org/0000-0001-9596-1733
Martinez-Majander, Nicolas https://orcid.org/0000-0001-8489-7051
Sinisalo, Juha https://orcid.org/0000-0002-0169-5137
Putaala, Jukka https://orcid.org/0000-0002-6630-6104
Midtbø, Helga https://orcid.org/0000-0002-3558-9914
,
Funding for this research was provided by:
University of Bergen
Article History
Received: 16 December 2025
Accepted: 10 February 2026
First Online: 27 March 2026
Declarations
:
: The authors declared no potential conflict of interest with respect to the research, authorship, and/or publication of this article. EG Speaker’s fee from Boehringer Ingelheim, Amgen, Menarini Foundation, OMRON. EG is a nucleus member of the European Society of Cardiology Council on hypertension. HM received speaker fees from Boehringer Ingelheim, Pfizer and Bayer. AS received consultancy or lecture fees from Abbott, Astra Zeneca, BMS, Novo Nordic and Pfizer. The other authors did not report any potential conflicts of interest.